We subsequently formulated a more precise probe, [18F]CFA, which was Employed in The present study to evaluate dCK activity in tumors when treated with a little molecule dCK inhibitor. This probe can be being analyzed in the medical demo at our institution to evaluate changes in dCK exercise followi